Bristol-Myers Squibb Co.'s former medical imaging unit in Billerica has a new name and management team.
Avista Capital Partners, which bought the company from Bristol-Myers in January for $525 million, has renamed the operation Lantheus Medical Imaging.
The new chief executive is Don Kiepert, who previously founded and ran Point Therapeutics, which merged with Dara BioSciences in October.
Lantheus, which has 700 employees, provides medical imaging products for ultrasound and other diagnostic procedures.
(By Todd Wallack, Globe staff)